{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:08:19Z","timestamp":1788883699200,"version":"build-2803163510"},"reference-count":99,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100006129","name":"FCT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013239","name":"CESAM","doi-asserted-by":"publisher","award":["UID\/50017\/2025"],"award-info":[{"award-number":["UID\/50017\/2025"]}],"id":[{"id":"10.13039\/100013239","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013239","name":"CESAM","doi-asserted-by":"publisher","award":["LA\/P\/0094\/2020"],"award-info":[{"award-number":["LA\/P\/0094\/2020"]}],"id":[{"id":"10.13039\/100013239","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To evaluate the efficacy of bacteriophage\u2013antibiotic combination therapy against major urinary tract infection (UTI) pathogens and determine whether combining phages with ciprofloxacin enhances bacterial killing, delays resistance emergence, and improves treatment performance under physiologically relevant conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Five clinically relevant UTI pathogens were tested: Escherichia coli (UPEC), Enterococcus faecalis, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Proteus mirabilis. Phages from a commercially available cocktail were screened and supplemented with a lab-isolated phage to improve E. coli coverage. In vitro assays evaluated bacterial inactivation using phages alone and in combination with ciprofloxacin at varying concentrations, including sub-MIC levels. Resistance emergence and associated fitness costs were assessed. Ex vivo efficacy was further tested using filtered human urine to simulate physiologically relevant conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Phage\u2013antibiotic combinations significantly enhanced bacterial inactivation across all tested species compared to monotherapies, including at sub-MIC ciprofloxacin concentrations. Combination treatments delayed resistance development and imposed fitness costs on resistant E. coli mutants. Ex vivo urine assays confirmed that phages remained effective in physiologically relevant conditions, particularly in combination regimens, despite reduced antibiotic efficacy in urine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Phage\u2013antibiotic combination therapy improves bacterial killing, suppresses resistance emergence, and remains effective in urine-based models. These findings support integrating phage therapy with conventional antibiotics as a promising strategy for UTI management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jambio\/lxag211","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T11:45:13Z","timestamp":1787399113000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of phage-antibiotic combinations in the inactivation of urinary tract infection-related bacteria"],"prefix":"10.1093","volume":"137","author":[{"given":"Tiago","family":"Leal","sequence":"first","affiliation":[{"name":"CESAM, Department of Biology, University of Aveiro , Campus Universit\u00e1rio de Santiago, 3810-193 Aveiro ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Costa","sequence":"additional","affiliation":[{"name":"CESAM, Department of Biology, University of Aveiro , Campus Universit\u00e1rio de Santiago, 3810-193 Aveiro ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Pereira","sequence":"additional","affiliation":[{"name":"CESAM, Department of Biology, University of Aveiro , Campus Universit\u00e1rio de Santiago, 3810-193 Aveiro ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelaide","family":"Almeida","sequence":"additional","affiliation":[{"name":"CESAM, Department of Biology, University of Aveiro , Campus Universit\u00e1rio de Santiago, 3810-193 Aveiro ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"key":"2026090811145439300_bib1","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1089\/fpd.2008.0242","article-title":"Kinetics of phage-mediated biocontrol of bacteria","volume":"6","author":"Abedon","year":"2009","journal-title":"Foodborne Pathog. Dis."},{"key":"2026090811145439300_bib2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/antibiotics8040182","article-title":"Phage-antibiotic combination treatments: antagonistic impacts of antibiotics on the pharmacodynamics of phage therapy?","volume":"8","author":"Abedon","year":"2019","journal-title":"Antibiotics"},{"key":"2026090811145439300_bib3","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3390\/ph14111157","article-title":"Phage therapy in the 21st century: Is there modern, clinical evidence of phage-mediated efficacy?","volume":"14","author":"Abedon","year":"2021","journal-title":"Pharmaceuticals"},{"key":"2026090811145439300_bib4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2017.00981","article-title":"Editorial: phage therapy: Past, present and future","volume":"8","author":"Abedon","year":"2017","journal-title":"Front Microbiol"},{"key":"2026090811145439300_bib5","doi-asserted-by":"publisher","DOI":"10.5962\/bhl.title.6966","volume-title":"Bacteriophages","author":"Adams","year":"1959"},{"key":"2026090811145439300_bib6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/antibiotics8030103","article-title":"Synergistic action of phage and antibiotics: Parameters to enhance the killing efficacy against mono and dual-species biofilms","volume":"8","author":"Akturk","year":"2019","journal-title":"Antibiotics"},{"key":"2026090811145439300_bib7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1089\/phage.2023.0024","article-title":"Phage therapy in the management of urinary tract infections: A comprehensive systematic review","volume":"4","author":"Al-Anany","year":"2023","journal-title":"PHAGE: Ther. Appl. Res."},{"key":"2026090811145439300_bib8","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s10295-008-0446-2","article-title":"Photodynamic inactivation of recombinant bioluminescent Escherichia coli by cationic porphyrins under artificial and solar irradiation","volume":"35","author":"Alves","year":"2008","journal-title":"J Ind Microbiol Biotechnol"},{"key":"2026090811145439300_bib9","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nrmicro2319","article-title":"Antibiotic resistance and its cost: Is it possible to reverse resistance?","volume":"8","author":"Andersson","year":"2010","journal-title":"Nat Rev Micro"},{"key":"2026090811145439300_bib10","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1080\/22221751.2020.1747950","article-title":"Non-active antibiotic and bacteriophage synergism to successfully treat recurrent urinary tract infection caused by extensively drug-resistant Klebsiella pneumoniae","volume":"9","author":"Bao","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"2026090811145439300_bib11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/ajcp\/45.4_ts.493","article-title":"Antibiotic susceptibility testing by a standardized single disk method","volume":"45","author":"Bauer","year":"1966","journal-title":"Am J Clin Pathol"},{"key":"2026090811145439300_bib12","doi-asserted-by":"publisher","first-page":"e0193524","DOI":"10.1128\/aac.01935-24","article-title":"Studies in vitro and in vivo of phage therapy medical products (PTMPs) targeting clinical strains of Klebsiella pneumoniae belonging to the clone ST512","volume":"69","author":"Bleriot","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"2026090811145439300_bib13","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1007\/s00345-013-1218-9","article-title":"Healthcare-associated urinary tract infections in hospitalized urological patients\u2014A global perspective: Results from the GPIU studies 2003\u20132010","volume":"32","author":"Cek","year":"2014","journal-title":"World J Urol"},{"key":"2026090811145439300_bib14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0924-8579(99)00033-3","article-title":"Inhibitors of bacterial growth in urine: What is the role of betaines?","volume":"11","author":"Chambers","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"2026090811145439300_bib15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-394805-2.00001-4","article-title":"Phage therapy pharmacology: Phage cocktails","volume-title":"Advances in Applied Microbiology","author":"Chan","year":"2012"},{"key":"2026090811145439300_bib16","doi-asserted-by":"publisher","first-page":"e0168615","DOI":"10.1371\/journal.pone.0168615","article-title":"Synergy and order effects of antibiotics and phages in killing Pseudomonas aeruginosa biofilms","volume":"12","author":"Chaudhry","year":"2017","journal-title":"PLoS One"},{"key":"2026090811145439300_bib17","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3390\/antibiotics10080974","article-title":"Application of the resazurin cell viability assay to monitor Escherichia coli and Salmonella Typhimurium inactivation mediated by phages","volume":"10","author":"Costa","year":"2021","journal-title":"Antibiotics"},{"key":"2026090811145439300_bib18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/microorganisms7040094","article-title":"Efficiency of single phage suspensions and phage cocktail in the inactivation of Escherichia coli and Salmonella Typhimurium: An in vitro preliminary study","volume":"7","author":"Costa","year":"2019","journal-title":"Microorganisms"},{"key":"2026090811145439300_bib19","doi-asserted-by":"publisher","first-page":"111096","DOI":"10.1016\/j.ijfoodmicro.2025.111096","article-title":"Characterising phages for the control of pathogenic bacteria associated with bivalve consumption","volume":"432","author":"Costa","year":"2025","journal-title":"Int. J. Food Microbiol."},{"key":"2026090811145439300_bib20","doi-asserted-by":"publisher","first-page":"110209","DOI":"10.1016\/j.virol.2024.110209","article-title":"A game of resistance: War between bacteria and phages and how phage cocktails can be the solution","volume":"599","author":"Costa","year":"2024","journal-title":"Virology"},{"key":"2026090811145439300_bib21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/antibiotics13020195","article-title":"Potential of an isolated bacteriophage to inactivate Klebsiella pneumoniae: Preliminary studies to control urinary tract infections","volume":"13","author":"Duarte","year":"2024","journal-title":"Antibiotics"},{"key":"2026090811145439300_bib22","article-title":"Annual Epidemiological Report for 2018: Healthcare- associated infections acquired in intensive care units","volume-title":"ECDC. Annual Epidemiological Report","author":"European Center for Disease Prevention and Control","year":"2018"},{"key":"2026090811145439300_bib23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0025486","article-title":"Bacteriophage-resistant mutants in Yersinia pestis: Identification of phage receptors and attenuation for mice","volume":"6","author":"Filippov","year":"2011","journal-title":"PLoS One"},{"key":"2026090811145439300_bib24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: Epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Flores-Mireles","year":"2015","journal-title":"Nat Rev Micro"},{"key":"2026090811145439300_bib25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.idc.2013.09.003","article-title":"Urinary tract infection syndromes","volume":"28","author":"Foxman","year":"2014","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"2026090811145439300_bib26","doi-asserted-by":"publisher","first-page":"e73685","DOI":"10.7759\/cureus.73685","article-title":"Emphysematous cystitis and septic shock: A multidisciplinary approach to managing a life-threatening urological infection","volume-title":"Cureus","author":"Fraz\u00e3o","year":"2024"},{"key":"2026090811145439300_bib27","doi-asserted-by":"publisher","first-page":"1401234","DOI":"10.3389\/fmicb.2024.1401234","article-title":"Using phage to drive selections toward restoring antibiotic sensitivity in Pseudomonas aeruginosa via chromosomal deletions","volume":"15","author":"Fujiki","year":"2024","journal-title":"Front Microbiol"},{"key":"2026090811145439300_bib28","doi-asserted-by":"publisher","first-page":"15628","DOI":"10.3390\/ijms242115628","article-title":"Fitness trade-offs between phage and antibiotic sensitivity in phage-resistant variants: Molecular action and insights into clinical applications for phage therapy","volume":"24","author":"Fujiki","year":"2023","journal-title":"IJMS"},{"key":"2026090811145439300_bib29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1089\/phage.2023.0007","article-title":"Two is better than One\u2019: The multifactorial nature of phage-antibiotic combinatorial treatments against ESKAPE-induced infections","volume":"4","author":"Fungo","year":"2023","journal-title":"PHAGE: Ther. Appl. Res."},{"key":"2026090811145439300_bib30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/antibiotics8030131","article-title":"Phage therapy with a focus on the human microbiota","volume":"8","author":"Ganeshan","year":"2019","journal-title":"Antibiotics"},{"key":"2026090811145439300_bib31","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2026090811145439300_bib32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/emph\/eoaa026","article-title":"Phage steering of antibiotic-resistance evolution in the bacterial pathogen, Pseudomonas aeruginosa","volume":"2020","author":"Gurney","year":"2020","journal-title":"Evol Med Public Heal"},{"key":"2026090811145439300_bib33","first-page":"17","article-title":"Measurement of mutation to antibiotic resistance: Ampicillin resistance in Serratia marcescens","volume":"26","author":"Haddix","year":"2000","journal-title":"Bioscene"},{"key":"2026090811145439300_bib34","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.1038\/s41598-025-89240-5","article-title":"Epidemiological trends and predictions of urinary tract infections in the global burden of disease study 2021","volume":"15","author":"He","year":"2025","journal-title":"Sci Rep"},{"key":"2026090811145439300_bib35","doi-asserted-by":"publisher","first-page":"e02016","DOI":"10.1128\/spectrum.02016-22","article-title":"Bacterial growth of uropathogenic Escherichia coli in pooled urine is much higher than predicted from the average growth in individual urine samples","volume":"10","author":"Hogins","year":"2022","journal-title":"Microbiol Spectr"},{"key":"2026090811145439300_bib36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/nyas.12830","article-title":"Mechanisms of drug resistance: Quinolone resistance","volume":"1354","author":"Hooper","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2026090811145439300_bib37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.mib.2019.10.008","article-title":"Antibiotics: Past, present and future","volume":"51","author":"Hutchings","year":"2019","journal-title":"Curr. Opin. Microbiol."},{"key":"2026090811145439300_bib38","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.tim.2018.08.006","article-title":"Molecular and evolutionary determinants of bacteriophage host range","volume":"27","author":"Jonge","year":"2019","journal-title":"Trends Microbiol."},{"key":"2026090811145439300_bib39","doi-asserted-by":"publisher","first-page":"fuaf061","DOI":"10.1093\/femsre\/fuaf061","article-title":"Phage cocktails: State-of-the-art technologies and strategies for effective design","volume":"50","author":"Kaneko","year":"2026","journal-title":"FEMS Microbiol Rev"},{"key":"2026090811145439300_bib40","doi-asserted-by":"publisher","first-page":"e02085","DOI":"10.1128\/AEM.02085-18","article-title":"Phage-antibiotic synergy via delayed lysis","volume":"84","author":"Kim","year":"2018","journal-title":"Appl Environ Microb"},{"key":"2026090811145439300_bib41","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.chom.2019.01.014","article-title":"Phage therapy: A renewed approach to combat antibiotic-resistant bacteria","volume":"25","author":"Kortright","year":"2019","journal-title":"Cell Host & Microbe"},{"key":"2026090811145439300_bib42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.eururo.2024.03.035","article-title":"European Association of Urology guidelines on urological infections: Summary of the 2024 guidelines","volume":"86","author":"Kranz","year":"2024","journal-title":"European Urology"},{"key":"2026090811145439300_bib43","doi-asserted-by":"publisher","first-page":"10.1128\/aac.01281","DOI":"10.1128\/AAC.01281-19","article-title":"A Dutch case report of successful treatment of chronic relapsing urinary tract infection with bacteriophages in a renal transplant patient","volume":"64","author":"Kuipers","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2026090811145439300_bib44","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-1-60327-164-6_14","article-title":"Phage host range and efficiency of plating","volume-title":"Bacteriophage: Methods and Protocols","author":"Kutter","year":"2009"},{"key":"2026090811145439300_bib45","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrmicro2315","article-title":"Bacteriophage resistance mechanisms","volume-title":"Nat Rev Microbiol","author":"Labrie","year":"2010"},{"key":"2026090811145439300_bib46","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3390\/v14051079","article-title":"In vitro and in vivo assessments of two newly isolated bacteriophages against an ST13 urinary tract infection Klebsiella pneumoniae","volume":"14","author":"Lafor\u00eat","year":"2022","journal-title":"Viruses"},{"key":"2026090811145439300_bib47","doi-asserted-by":"publisher","first-page":"e00037","DOI":"10.1128\/aac.00037-23","article-title":"Therapeutic potential of intravenous phage as standalone therapy for recurrent drug-resistant urinary tract infections","volume":"67","author":"Le","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"2026090811145439300_bib48","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.7150\/ijbs.60551","article-title":"A combination therapy of phages and antibiotics: Two is better than one","volume":"17","author":"Li","year":"2021","journal-title":"Int J Biol Sci"},{"key":"2026090811145439300_bib49","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4292\/wjgpt.v8.i3.162","article-title":"Phage therapy: An alternative to antibiotics in the age of multi-drug resistance","volume":"8","author":"Lin","year":"2017","journal-title":"WJGPT"},{"key":"2026090811145439300_bib50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2334-13-19","article-title":"Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: A ten-year surveillance study (2000\u20132009)","volume":"13","author":"Linhares","year":"2013","journal-title":"BMC Infect Dis"},{"key":"2026090811145439300_bib51","doi-asserted-by":"publisher","first-page":"1356179","DOI":"10.3389\/fphar.2024.1356179","article-title":"Phage-antibiotic combinations in various treatment modalities to manage MRSA infections","volume":"15","author":"Loganathan","year":"2024","journal-title":"Front Pharmacol"},{"key":"2026090811145439300_bib52","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/microorganisms6040125","article-title":"Sequential combined effect of phages and antibiotics on the inactivation of Escherichia coli","volume":"6","author":"Lopes","year":"2018","journal-title":"Microorganisms"},{"key":"2026090811145439300_bib53","doi-asserted-by":"publisher","first-page":"283","DOI":"10.4014\/jmb.1110.10041","article-title":"Isolation of surfactant-resistant Pseudomonads from the estuarine surface microlayer","volume":"22","author":"Louvado","year":"2012","journal-title":"J Microbiol Biotechnol"},{"key":"2026090811145439300_bib54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12929-022-00806-1","article-title":"Bacteriophages and antibiotic interactions in clinical practice: What we have learned so far","volume":"29","author":"\u0141usiak-Szelachowska","year":"2022","journal-title":"J Biomed Sci"},{"key":"2026090811145439300_bib55","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","article-title":"Multistate point-prevalence survey of health care\u2013associated infections","volume":"370","author":"Magill","year":"2014","journal-title":"N Engl J Med"},{"key":"2026090811145439300_bib56","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s12223-019-00750-y","article-title":"Managing urinary tract infections through phage therapy: A novel approach","volume":"65","author":"Malik","year":"2020","journal-title":"Folia Microbiol"},{"key":"2026090811145439300_bib57","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/pathogens12040623","article-title":"Urinary tract infections: The current scenario and future prospects","volume":"12","author":"Mancuso","year":"2023","journal-title":"Pathogens"},{"key":"2026090811145439300_bib58","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1021\/acsinfecdis.1c00117","article-title":"Synergistic effects of phage\u2013antibiotic combinations against Citrobacter amalonaticus","volume":"8","author":"Manohar","year":"2022","journal-title":"ACS Infect Dis"},{"key":"2026090811145439300_bib59","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.3390\/microorganisms12091795","article-title":"The potential of phage treatment to inactivate planktonic and biofilm-forming Pseudomonas aeruginosa","volume":"12","author":"Martinho","year":"2024","journal-title":"Microorganisms"},{"key":"2026090811145439300_bib60","doi-asserted-by":"publisher","DOI":"10.21877\/2448-3877.202000861","article-title":"Diagn\u00f3stico laboratorial das infec\u00e7\u00f5es urin\u00e1rias: Rela\u00e7\u00e3o entre a urocultura e o EAS","volume":"52","author":"Masson","year":"2020","journal-title":"Rev Bras An\u00e1l. Cl\u00edn."},{"key":"2026090811145439300_bib61","doi-asserted-by":"publisher","first-page":"1756287219832172","DOI":"10.1177\/1756287219832172","article-title":"An introduction to the epidemiology and burden of urinary tract infections","volume":"11","author":"Medina","year":"2019","journal-title":"Ther. Adv. Urol."},{"key":"2026090811145439300_bib62","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/eva.12196","article-title":"The fitness costs of antibiotic resistance mutations","volume":"8","author":"Melnyk","year":"2015","journal-title":"Evol. Appl."},{"key":"2026090811145439300_bib63","doi-asserted-by":"publisher","first-page":"257","DOI":"10.22038\/IJBMS.2019.37561.8989","article-title":"Synergistic bactericidal activity of a naturally isolated phage and ampicillin against urinary tract infecting Escherichia coli O157","volume":"23","author":"Moradpour","year":"2020","journal-title":"Iran J Basic Med Sci"},{"key":"2026090811145439300_bib64","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"2026090811145439300_bib65","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/nyas.14533","article-title":"Phage-antibiotic combinations: A promising approach to constrain resistance evolution in bacteria","volume":"1496","author":"North","year":"2021","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2026090811145439300_bib66","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.acuroe.2023.02.002","article-title":"Urinary pH and antibiotics, choose carefully. A systematic review","volume":"47","author":"Ordaz","year":"2023","journal-title":"Actas Urol. Esp. (Engl. Ed.)"},{"key":"2026090811145439300_bib67","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3855\/jidc.19592","article-title":"Antibiotic resistance trends in ESKAPE pathogens isolated at a health practice and research hospital: A five-year retrospective study","volume":"18","author":"Orhan","year":"2024","journal-title":"J Infect Dev Ctries"},{"key":"2026090811145439300_bib68","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.3390\/microorganisms12102084","article-title":"Overview of antimicrobial resistant ESKAPEE pathogens in food sources and their implications from a One Health perspective","volume":"12","author":"Oyenuga","year":"2024","journal-title":"Microorganisms"},{"key":"2026090811145439300_bib69","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3390\/idr16060092","article-title":"Advancing phage therapy: A comprehensive review of the safety, efficacy, and future prospects for the targeted treatment of bacterial infections","volume":"16","author":"Palma","year":"2024","journal-title":"Infect Dis Rep"},{"key":"2026090811145439300_bib70","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.virusres.2016.09.019","article-title":"Characterisation and in vitro evaluation of new bacteriophages for the biocontrol of Escherichia coli","volume":"227","author":"Pereira","year":"2017","journal-title":"Virus Res."},{"key":"2026090811145439300_bib71","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.virusres.2015.10.025","article-title":"Potential of phage cocktails in the inactivation of Enterobacter cloacae\u2014an in vitro study in a buffer solution and in urine samples","volume":"211","author":"Pereira","year":"2016","journal-title":"Virus Research"},{"key":"2026090811145439300_bib72","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1369-5274(00)00242-3","article-title":"Multidrug resistance in Gram-negative bacteria","volume":"4","author":"Poole","year":"2001","journal-title":"Curr Opin Microbiol"},{"key":"2026090811145439300_bib73","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1093\/genetics\/154.3.1335","article-title":"Genetics of mutations affecting the development of a barley floral bract","volume":"154","author":"Pozzi","year":"2000","journal-title":"Genetics"},{"key":"2026090811145439300_bib74","doi-asserted-by":"publisher","first-page":"e01393","DOI":"10.1128\/mbio.01393-24","article-title":"Phage-antibiotic synergy suppresses resistance emergence of Klebsiella pneumoniae by altering the evolutionary fitness","volume":"15","author":"Qin","year":"2024","journal-title":"mBio"},{"key":"2026090811145439300_bib75","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.tim.2014.04.007","article-title":"Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success","volume":"22","author":"Redgrave","year":"2014","journal-title":"Trends Microbiol."},{"key":"2026090811145439300_bib76","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.1038\/s41467-025-61055-y","article-title":"Phage-mediated peripheral kill-the-winner facilitates the maintenance of costly antibiotic resistance","volume":"16","author":"Ruan","year":"2025","journal-title":"Nat Commun"},{"key":"2026090811145439300_bib77","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/nrmicro2581","article-title":"Phage resistance comes at a cost","volume":"9","author":"Sanchez","year":"2011","journal-title":"Nat Rev Micro"},{"key":"2026090811145439300_bib78","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3390\/antibiotics11060768","article-title":"Revisiting the frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections","volume":"11","author":"Silva","year":"2022","journal-title":"Antibiotics"},{"key":"2026090811145439300_bib79","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.scitotenv.2018.05.229","article-title":"Fate of cefotaxime-resistant Enterobacteriaceae and ESBL-producers over a full-scale wastewater treatment process with UV disinfection","volume":"639","author":"Silva","year":"2018","journal-title":"Sci. Total Environ."},{"key":"2026090811145439300_bib80","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3390\/antibiotics10070849","article-title":"Synergy between phage Sb-1 and oxacillin against methicillin-resistant Staphylococcus aureus","volume":"10","author":"Simon","year":"2021","journal-title":"Antibiotics"},{"key":"2026090811145439300_bib81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/20905068.2020.1851441","article-title":"A review of phage mediated antibacterial applications","volume":"57","author":"Ssekatawa","year":"2021","journal-title":"Alex J Med"},{"key":"2026090811145439300_bib82","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1038\/s41564-025-02130-4","article-title":"Rational design of a hospital-specific phage cocktail to treat Enterobacter cloacae complex infections","volume":"10","author":"Subedi","year":"2025","journal-title":"Nat Microbiol"},{"key":"2026090811145439300_bib83","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/antibiotics14060545","article-title":"The current landscape of phage-antibiotic synergistic (PAS) interactions","volume":"14","author":"Supina","year":"2025","journal-title":"Antibiotics"},{"key":"2026090811145439300_bib84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2016.00465","article-title":"Bacteriophages as potential treatment for urinary tract infections","volume":"7","author":"Sybesma","year":"2016","journal-title":"Front Microbiol"},{"key":"2026090811145439300_bib85","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/mdr.2015.0072","article-title":"Low prevalence of carbapenem-resistant bacteria in river water: Resistance is mostly related to intrinsic mechanisms","volume":"21","author":"Tac\u00e3o","year":"2015","journal-title":"Microb. Drug Resist."},{"key":"2026090811145439300_bib86","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fcimb.2019.00022","article-title":"Fighting pathogenic bacteria on two fronts: Phages and antibiotics as combined strategy","volume":"9","author":"Tagliaferri","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"2026090811145439300_bib87","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.euf.2016.08.006","article-title":"Urinary tract Infections in immunocompromised patients with diabetes, chronic kidney disease, and kidney transplant","volume":"2","author":"Tandogdu","year":"2016","journal-title":"Eur. Urol. Focus"},{"key":"2026090811145439300_bib88","article-title":"Breakpoint tables for interpretation of MICs and zone diameters","author":"The European Committee on Antimicrobial Susceptibility Testing","year":"2024"},{"key":"2026090811145439300_bib89","doi-asserted-by":"publisher","first-page":"e106628","DOI":"10.1371\/journal.pone.0106628","article-title":"A window of opportunity to control the bacterial pathogen Pseudomonas aeruginosa combining antibiotics and phages","volume":"9","author":"Torres-Barcel\u00f3","year":"2014","journal-title":"PLoS One"},{"key":"2026090811145439300_bib90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2018.01832","article-title":"Adapted bacteriophages for treating urinary tract infections","volume":"9","author":"Ujmajuridze","year":"2018","journal-title":"Front Microbiol"},{"key":"2026090811145439300_bib91","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.virusres.2017.07.015","article-title":"Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli","volume":"240","author":"Val\u00e9rio","year":"2017","journal-title":"Virus Res"},{"key":"2026090811145439300_bib92","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1007\/s10096-012-1691-x","article-title":"Phage therapy to control multidrug-resistant Pseudomonas aeruginosa skin infections: in vitro and ex vivo experiments","volume":"31","author":"Vieira","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026090811145439300_bib93","doi-asserted-by":"publisher","first-page":"35","DOI":"10.20517\/mrr.2025.31","article-title":"Phage therapy as a revitalized weapon for treating clinical diseases","volume":"4","author":"Wang","year":"2025","journal-title":"Microbiome Res Rep"},{"key":"2026090811145439300_bib94","doi-asserted-by":"publisher","first-page":"e01356","DOI":"10.1128\/spectrum.01356-22","article-title":"Phage resistance evolution induces the sensitivity of specific antibiotics in Pseudomonas aeruginosa PAO1","volume":"10","author":"Xuan","year":"2022","journal-title":"Microbiol Spectr"},{"key":"2026090811145439300_bib95","doi-asserted-by":"publisher","first-page":"888205","DOI":"10.3389\/fpubh.2022.888205","article-title":"Disease burden and long-term trends of urinary tract infections: a worldwide report","volume":"10","author":"Yang","year":"2022","journal-title":"Front Public Health"},{"key":"2026090811145439300_bib96","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3390\/antibiotics14101040","article-title":"Phage therapy as a novel alternative to antibiotics through adaptive evolution and fitness trade-offs","volume":"14","author":"Zhang","year":"2025","journal-title":"Antibiotics"},{"key":"2026090811145439300_bib97","doi-asserted-by":"publisher","first-page":"10537","DOI":"10.3390\/ijms241310537","article-title":"Urinary tract infections caused by uropathogenic Escherichia coli: mechanisms of infection and treatment options","volume":"24","author":"Zhou","year":"2023","journal-title":"IJMS"},{"key":"2026090811145439300_bib98","doi-asserted-by":"publisher","first-page":"eesp","DOI":"10.1128\/ecosalplus.esp-0029-2023","article-title":"The rise, fall, and resurgence of phage therapy for urinary tract infection","volume":"12","author":"Zulk","year":"2024","journal-title":"EcoSal Plus"},{"key":"2026090811145439300_bib99","doi-asserted-by":"publisher","first-page":"15188","DOI":"10.1038\/s41598-023-42505-3","article-title":"Bacteriophages with depolymerase activity in the control of antibiotic resistant Klebsiella pneumoniae biofilms","volume":"13","author":"Zurabov","year":"2023","journal-title":"Sci Rep"}],"container-title":["Journal of Applied Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jambio\/advance-article-pdf\/doi\/10.1093\/jambio\/lxag211\/70763066\/lxag211.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jambio\/article-pdf\/137\/9\/lxag211\/70763066\/lxag211.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jambio\/article-pdf\/137\/9\/lxag211\/70763066\/lxag211.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:24:46Z","timestamp":1788881086000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jambio\/article\/doi\/10.1093\/jambio\/lxag211\/8768583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":99,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jambio\/lxag211","relation":{},"ISSN":["1365-2672"],"issn-type":[{"value":"1365-2672","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,8,22]]},"article-number":"lxag211"}}